Your browser doesn't support javascript.
A Global Early Empirical Therapy Randomized Study Design for Ivermectin in SARS-CoV-2 Infection.
Bhaskar, Emmanuel.
  • Bhaskar E; Department of Medicine, Sri Ramachandra Medical College and Research Institute, Porur, Chennai, India.
Am J Ther ; 28(4): e522-e523, 2021 05 28.
Article in English | MEDLINE | ID: covidwho-1266228
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Ivermectin / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2021 Document Type: Article Affiliation country: Mjt.0000000000001399

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Ivermectin / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Am J Ther Journal subject: Therapeutics Year: 2021 Document Type: Article Affiliation country: Mjt.0000000000001399